BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/16/2026 9:18:03 AM | Browse: 1 | Download: 0
Publication Name World Journal of Cardiology
Manuscript ID 121611
DOI 10.4330/wjc.121611
Country United States
Category Cardiac & Cardiovascular Systems
Manuscript Type Meta-Analysis
Article Title Dose-dependent efficacy of olezarsen in high-risk hypertriglyceridemia: A meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Vyom Patel, Rohab Sohail, Madihah Alam, Shahryar Chaudhry, Samar Mehdi, Simran Patel, Rohan Patel, Ridda Khattak, Zaraq Khan and Manan Patel
Funding Agency and Grant Number
Corresponding Author Vyom Patel, MD, Principal Investigator, Department of Internal Medicine, Indiana University School of Medicine, INDIANA UNIVERSITY SCHOOL OF MEDICINE, Department of Internal Medicine, Indiana University School of Medicine, Southwest Internal Medicine Residency Program, Evansville, Indiana, USA. Electronic address: vyompate@iu.edu, Evansville, IN 47591, United States. vyompate@iu.edu
Key Words Olezarsen; Dose-dependent effectiveness; Side-effects; Apolipoprotein C-III; Hypertriglyceridemia
Core Tip This meta-analysis of three randomized controlled trials is the first to directly compare olezarsen 80 mg vs 50 mg in patients with high-risk hypertriglyceridemia. While the 80 mg dose produced a statistically significant incremental reduction in apolipoprotein C-III (apoC-III), no significant differences were observed in triglyceride, non-high-density lipoprotein cholesterol, or safety outcomes. These findings suggest that higher dosing confers limited added benefit beyond apoC-III suppression, though equivalence cannot be established from the available evidence.
Citation Patel V, Sohail R, Alam M, Chaudhry S, Mehdi S, Patel S, Patel R, Khattak R, Khan Z, Patel M. Dose-dependent efficacy of olezarsen in high-risk hypertriglyceridemia: A meta-analysis. World J Cardiol 2026; In press
PDF 121611-in-press.pdf
Received
2026-03-30 01:58
Peer-Review Started
2026-03-31 03:33
First Decision by Editorial Office Director
2026-04-13 08:31
Return for Revision
2026-04-13 08:31
Revised
2026-05-02 03:14
Publication Fee Transferred
2026-05-11 02:16
Second Decision by Editor
2026-06-16 02:34
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-16 09:18
Articles in Press
2026-06-16 09:18
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1949-8462 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com